US probing JUUL's 'deceptive' social media marketing: report
US regulators are looking into potentially "deceptive marketing" used by popular e-cigarette brand JUUL Labs that targeted teens, according to a news report Thursday.
Aug 29, 2019
0
12
US regulators are looking into potentially "deceptive marketing" used by popular e-cigarette brand JUUL Labs that targeted teens, according to a news report Thursday.
Aug 29, 2019
0
12
Amgen has agreed to acquire the global rights to Otezla, a drug used for the treatment of psoriasis and psoriatic arthritis, for $13.4 billion in cash, Bristol Myers Squibb said Monday.
Aug 26, 2019
0
2
British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.
Jul 11, 2019
0
1
U.S. health authorities are alerting consumers to a new scam involving fake government warning letters sent to people who tried to buy medicines online or over the phone.
Jul 13, 2018
0
2
A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.
Jan 9, 2017
0
1
New York state has launched an antitrust probe into Mylan's sale of the EpiPen anti-allergy injector to local school systems, New York's attorney general announced Tuesday.
Sep 6, 2016
0
3
Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.5 billion purchase of the generic drug business of competitor Allergan next week after federal regulators ...
Jul 27, 2016
0
5
Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million.
Sep 18, 2015
0
6
Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.
Aug 24, 2015
0
10
Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.
Apr 20, 2015
0
7